AzTrials
AzTrials

HealthyNCT03219398

The Effect of Lower Intraabdominal Pressure on Syndecan-1, sVEGF-R2, Occludin, KIM-1, and IL-6 on Living Donor Laparoscopic Nephrectomy

A study testing Pneumoperitoneum pressure in people with Healthy, run by Universitas Indonesia at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to evaluate the increase of intraabdominal pressure 12- 14 mmHg caused by pneumoperitoneum resulted from carbon dioxide (CO2) insufflation induce glycocalyx endothelial injury that cause kidney tubular injury on live donor patient that undergo laparoscopic nephrectomy surgery, and decreasing the… Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Pneumoperitoneum pressure
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteIndonesia
Study dates
1 Aug 2017to 1 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Subjects aged 18-60 years old undergoing laparoscopic surgery, with American Society of Anesthesiologist (ASA) 1, body mass index 18-25. Patients who agreed to participate in this study and sign informed consent.

Who cannot join

  • Subjects in the outside criteria of American Society of Anesthesia 1, body mass index >25.

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Cipto Mangunkusumo Central National Hospital

    Jakarta, DKI Jakarta, 10430

Other trials in Indonesia

About this study

Official title: Comparison Effect Between Lower Pressure and Standard Pressure Pneumoperitoneum on Sign of Acute Systemic Inflammation, Endothelial Injury, and Acute Kidney Injury: A Randomized Clinical Trial in Living Donor Laparoscopic Nephrectomy

This study aimed to evaluate the increase of intraabdominal pressure 12- 14 mmHg caused by pneumoperitoneum resulted from carbon dioxide (CO2) insufflation induce glycocalyx endothelial injury that cause kidney tubular injury on live donor patient that undergo laparoscopic nephrectomy surgery, and decreasing the intraabdominal pressure to 8-10 mmHg during surgery is expected to reduce the injury.

Read the detailed description

Approval from Ethical Committee of Faculty of Medicine Universitas Indonesia was acquired prior conducting the study. Subjects were given informed consent before enrolling the study and randomized into two groups. Intravenous (IV) cannula (18-20G) with Ringer Lactate fluid, non-invasive blood pressure monitor, electrocardiogram (ECG), ICON® monitor, hemodynamic monitor and pulse-oxymetry were set on the subjects in the operation room. Premedication with 2 mg IV midazolam and 1 mcg/kg IV fentanyl as premedication. General anesthesia induction was done by fentanyl 4 mcg/kg, propofol 1-2 mg/kg, and rocuronium 0,5 mg/kg. Maintenance was done by sevoflurane 1 minimum alveolar concentration (MAC), fentanyl and rocuronium with bupivacaine bolus 6ml every 90 minutes. Surgery starts with patient in lumbotomy position laterally, CO2 gas insufflated during the installment of laparoscopy probe until it reaches 10- 12 mmHg pressure. Laparoscopy targeted the pneumoperitoneum pressure until 8- 10 mmHg or 12- 14 mmHg depends on subject randomization. Surgery duration, blood pressure, heart rate, respiratory rate, oxygen saturation (SpO2) were recorded. During surgery, blood sample for interleukin (IL)-6, Syndecan-1, sVGEF-R2, Occludin and KIM-1 urine were taken before the anesthesia induction as the baseline; 2 hours of gas insufflation intraoperatively; and 2 hours after gas desufflation. The measurement of renal artery and kidney lobe artery that undergo nephrectomy, will be measured by convex probe 3.5-5 megahertz (MHz) ultrasonography (USG) Logic 7-GE or Sonosite. The measurement of RI was done on the left kidney at the time: before the anesthesia induction as the baseline; 2 hours of gas insufflation intraoperatively; and 2 hours after gas desufflation on the remaining right kidney. All patients received bilateral Quadratus Lumborum (QL) block using bupivacaine 0.25% before extubation. Patient were extubated until fully conscious and can follow command verbally. Patient will be transported in recovery room post operation. Data was analyzed using SPSS (Statistical Package for Social Scientist), for parametric unpaired data is using unpaired T-test or One way ANOVA test, ffor unpaired non parametric data using Mann Whitney or Kruskal-Wallis. Non Parametric continuous data using Wilcoxon's signed rank test or Friedman Test. Categorical data using Chi-square. For numerical data more than 1 measurement will be analysed using Comparative General Linear Model. Data normality was tested by Kolmogorov-Smirnov test. Significant value is p<0.05.

Conditions
Healthy
Being tested
Pneumoperitoneum pressure
Keywords
Living donor laparoscopic nephrectomy, Pneumoperitoneum, Renal resistive index, Syndecan-1, soluble VEGF-R2, Occludin, KIM-1, Interleukin-6
Medical subject headings
Pneumoperitoneum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pneumoperitoneum pressureProcedure or surgery

    Subjects were set to 8- 10 mmHg pressure during laparoscopic surgery; Subjects were set to 12-14 mmHg pressure during laparoscopic surgery

Study groups in NCT03219398
Study groupRoleWhat they receive
8-10 mmHgActive comparatorPatients receive lower pneumoperitoneum pressure
Receives: Procedure: Pneumoperitoneum pressure
12-14 mmHgActive comparatorPatients receive higher pneumoperitoneum pressure
Receives: Procedure: Pneumoperitoneum pressure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Syndecan-1 level from baseline

    Measurement of plasma Syndecan-1 level after patient is sedated at baseline, 2 hours insufflation, and 2 hours after desufflation

    Measured: 24 hours

  2. Changes in sVGEFR-2 level from baseline

    Measurement of plasma soluble VGEF-R2 level after patient is sedated at baseline, 2 hours insufflation, and 2 hours after desufflation

    Measured: 24 hours

  3. Changes in KIM-1 level from baseline

    Measurement of Urinary KIM-1 level after patient is sedated at baseline, 2 hours insufflation, and 2 hours after desufflation

    Measured: 24 hours

  4. Changes in Interleukin-6 from baseline

    Measurement of plasma Interleukin-6 after patient is sedated at baseline, 2 hours insufflation, and 2 hours after desufflation

    Measured: 24 hours

Secondary outcomes (4)
  1. Changes in Renal Resistive Index from baseline

    Measurement of Renal artery resistive index using ultrasound after patient is sedated at baseline, 2 hours insufflation, and 2 hours after desufflation

    Measured: 24 hours

  2. Renal biopsy tissue Syndecan-1

    Histopathology and immunostaining Syndecan-1 of renal biopsy after donor kidney has been removed from patient and stored in ice

    Measured: 24 hours

  3. Intraoperative fentanyl dosage

    Comparison of fentanyl needs during operation

    Measured: 24 hours

  4. Changes in Occludin level from baseline

    Measurement of plasma Occludin level after patient is sedated at baseline, 2 hours insufflation, and 2 hours after desufflation

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2017
  2. Study start1 Aug 2017
  3. Primary completion1 Mar 2018
  4. Study completion1 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03219398
Sponsor's protocol ID
IndonesiaUAnes020
Status last verified
Mar 2019
First submitted
12 Jul 2017
Last updated
14 Mar 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Fehrman-Ekholm I, Lennerling A, Kvarnstrom N, Rizell M, Olausson M. [Living donor kidney transplantation--a successful story. Very cost-effective--and the donors live long with good health]. Lakartidningen. 2011 Nov 30-Dec 6;108(48):2492-5. No abstract available. Swedish.

    PubMed 22462270
  • Choi JD, Park JW, Choi JY, Kim HS, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI. Renal damage caused by warm ischaemia during laparoscopic and robot-assisted partial nephrectomy: an assessment using Tc 99m-DTPA glomerular filtration rate. Eur Urol. 2010 Dec;58(6):900-5. doi: 10.1016/j.eururo.2010.08.044. Epub 2010 Sep 15.

    PubMed 21414862
  • Vasdev N, Poon AS, Gowrie-Mohan S, Lane T, Boustead G, Hanbury D, Adshead JM. The physiologic and anesthetic considerations in elderly patients undergoing robotic renal surgery. Rev Urol. 2014;16(1):1-9.

    PubMed 24791150
  • Dalfino L, Tullo L, Donadio I, Malcangi V, Brienza N. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med. 2008 Apr;34(4):707-13. doi: 10.1007/s00134-007-0969-4. Epub 2007 Dec 19.

    PubMed 18157662
  • Mohmand H, Goldfarb S. Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol. 2011 Apr;22(4):615-21. doi: 10.1681/ASN.2010121222. Epub 2011 Feb 10.

    PubMed 21310818
  • Nguyen NT, Perez RV, Fleming N, Rivers R, Wolfe BM. Effect of prolonged pneumoperitoneum on intraoperative urine output during laparoscopic gastric bypass. J Am Coll Surg. 2002 Oct;195(4):476-83. doi: 10.1016/s1072-7515(02)01321-2.

    PubMed 12375752
  • Garg AX, Muirhead N, Knoll G, Yang RC, Prasad GV, Thiessen-Philbrook H, Rosas-Arellano MP, Housawi A, Boudville N; Donor Nephrectomy Outcomes Research (DONOR) Network. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int. 2006 Nov;70(10):1801-10. doi: 10.1038/sj.ki.5001819. Epub 2006 Sep 27.

    PubMed 17003822
  • Gomez-Anson B, Carrero-Lopez V, Diaz-Gonzalez R. Image-directed color Doppler ultrasound evaluation of the single kidney after unilateral nephrectomy in adults. J Clin Ultrasound. 1997 Jan;25(1):29-35. doi: 10.1002/(sici)1097-0096(199701)25:13.0.co;2-m.

    PubMed 9010805
  • Nekouei S, Ahmadnia H, Abedi M, Alamolhodaee MH, Abedi MS. Resistive index of the remaining kidney in allograft kidney donors. Exp Clin Transplant. 2012 Oct;10(5):454-7. doi: 10.6002/ect.2012.0054.

    PubMed 23031084
  • Lindberg F, Bergqvist D, Bjorck M, Rasmussen I. Renal hemodynamics during carbon dioxide pneumoperitoneum: an experimental study in pigs. Surg Endosc. 2003 Mar;17(3):480-4. doi: 10.1007/s00464-002-9044-y. Epub 2002 Nov 6.

    PubMed 12415336
  • Wiesenthal JD, Fazio LM, Perks AE, Blew BD, Mazer D, Hare G, Honey RJ, Pace KT. Effect of pneumoperitoneum on renal tissue oxygenation and blood flow in a rat model. Urology. 2011 Jun;77(6):1508.e9-15. doi: 10.1016/j.urology.2011.02.022. Epub 2011 Apr 19.

    PubMed 21507469
  • Zacherl J, Thein E, Stangl M, Feussner H, Bock S, Mittlbock M, Erhardt W, Siewert JR. The influence of periarterial papaverine application on intraoperative renal function and blood flow during laparoscopic donor nephrectomy in a pig model. Surg Endosc. 2003 Aug;17(8):1231-6. doi: 10.1007/s00464-002-8835-5. Epub 2003 Jun 13.

    PubMed 12799887
  • Gudmundsson FF, Viste A, Myking OL, Bostad L, Grong K, Svanes K. Role of angiotensin II under prolonged increased intraabdominal pressure (IAP) in pigs. Surg Endosc. 2003 Jul;17(7):1092-7. doi: 10.1007/s00464-002-9123-0. Epub 2003 Mar 14.

    PubMed 12632126
  • Borba MR, Lopes RI, Carmona M, Neto BM, Nahas SC, Pereira PR. Effects of enalaprilat on the renin-angiotensin-aldosterone system and on renal function during CO2 pneumoperitoneum. J Endourol. 2005 Oct;19(8):1026-31. doi: 10.1089/end.2005.19.1026.

    PubMed 16253075
  • Demyttenaere S, Feldman LS, Fried GM. Effect of pneumoperitoneum on renal perfusion and function: a systematic review. Surg Endosc. 2007 Feb;21(2):152-60. doi: 10.1007/s00464-006-0250-x. Epub 2006 Dec 9.

    PubMed 17160650

Questions about this trial

What is this clinical trial studying?

A study testing Pneumoperitoneum pressure in people with Healthy, run by Universitas Indonesia at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Syndecan-1 level from baseline (time frame: 24 hours). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03219398, which also lists 122 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in